Immunic Inc Stock Performance
as on October 22, 2025 at 1:29 am IST
Day's Low
Day's High
$0.8$0.84
3.61%
Downside
1.20%
Upside
52 Week's Low
52 Week's High
$0.56$1.7332.41%
Downside
108.43%
Upside
Immunic Inc share price movements today
- Previous Close
- $0.84
- Open
- $0.83
- Volume
- 1.5M
- Day's Low - High
- $0.8 - $0.84
- 52 Week Low - High
- $0.56 - $1.73
Immunic Inc Historical Returns
- 1 Month Return
- -1.02 %
- 3 Month Return
- -10.22 %
- 1 Year Return
- -46.04 %
- 3 Year Return
- -59.79 %
- 5 Year Return
- -94.97 %
Immunic Inc Stock Fundamentals & Key Indicators
Check Immunic Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$79.0M
EPS (TTM)
-0.7263
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-105.1M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
735800.00%
Immunic Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Immunic Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $79.0M | -94.97% | NA | 0.00% | |
| BUY | $35.5B | 359.02% | -16.34 | -259.82% | |
| BUY | $63.1B | 259.92% | -505.15 | -12.96% | |
| BUY | $106.9B | 98.27% | 29.67 | 31.86% | |
| BUY | $61.3B | 0.76% | 14.58 | 31.37% |
Stock Returns calculator for Immunic Inc Stock including INR - Dollar returns
The Immunic Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Immunic Inc investment value today
Current value as on today
₹58,356
Returns
Returns from Immunic Inc Stock
Dollar Returns*
₹4,808 (+4.81%)
Analyst Recommendation on Immunic Inc Stock
Based on 11 analysts
81.82%
Buy
18.18%
Hold
0.00%
Sell
Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Immunic Inc. Average target price of $6.36
Immunic Inc Share Price Target
Get share price movements and forecasts by analysts on Immunic Inc.
What analysts predicted
86.95%UPSIDE
Target Price
$6.36
Current Price
$0.83
Analyzed by
11 Analysts
Target
$6.36
Immunic Inc target price $6.36, a slight upside of 86.95% compared to current price of $0.83. According to 11 analysts rating.
Immunic Inc Stock’s Investor Sentiment and Interest
Search interest for Immunic Inc Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Immunic Inc Quarterly Profit & Loss
All numbers in Millions USD
Immunic Inc Annual Profit & Loss
All numbers in Millions USD
Immunic Inc Quarterly Cash Flow
All numbers in Millions USD
Immunic Inc Annual Cash Flow
All numbers in Millions USD
Insights on Immunic Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Insmed Incorporated has given 132.3% return, outperforming this stock by 178.3%
- NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 809.6% return, outperforming this stock by 869.4%
NEGATIVE IMPACTPrice Dip
In the last 6 months, IMUX stock has moved down by -15.4%
About Immunic Inc
| Organisation | Immunic Inc |
| Headquarters | 1200 Avenue of the Americas, New York, NY, United States, 10036 |
| Industry | Pharmaceuticals: Major |
| CEO | Dr. Daniel Vitt Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Immunic Inc
Name | Title |
|---|---|
Mr. Jason Tardio M.B.A. | COO & President |
Mr. Glenn Whaley CPA | Chief Financial Officer |
Dr. Andreas Muehler M.D., Ph.D. | Chief Medical Officer |
Dr. Hella Kohlhof | Chief Scientific Officer |
Ms. Jessica Breu | Head of Investor Relations & Communications |
Mr. Patrick Walsh | Chief Business Officer |
Mr. Werner Gladdines | Chief Development Officer |
Dr. Duane D. Nash J.D., M.B.A., M.D. | Executive Chairman |
Dr. Daniel Vitt Ph.D. | CEO & Director |
Mr. Inderpal Singh | General Counsel |
FAQs
What is Immunic Inc share price today?
Immunic Inc share price today is $0.83 as on at the close of the market. Immunic Inc share today touched a day high of $0.84 and a low of $0.8.
What is the 52 week high and 52 week low for Immunic Inc share?
Immunic Inc share touched a 52 week high of $1.73 on and a 52 week low of $0.56 on . Immunic Inc stock price today i.e. is closed at $0.83,which is 52.02% down from its 52 week high and 47.95% up from its 52 week low.
What is Immunic Inc's market capitalisation today?
Immunic Inc market capitalisation is $0.00T as on .
How to invest in Immunic Inc Stock (IMUX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Immunic Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunic Inc Shares that will get you 1.8072 shares as per Immunic Inc share price of $0.83 per share as on October 22, 2025 at 1:29 am IST.
What is the minimum amount required to buy Immunic Inc Stock (IMUX) from India?
Indian investors can start investing in Immunic Inc (IMUX) shares with as little as ₹87.965 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.65 in Immunic Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Immunic Inc share’s latest price of $0.83 as on October 22, 2025 at 1:29 am IST, you will get 12.0482 shares of Immunic Inc. Learn more about
fractional shares .
What are the returns that Immunic Inc has given to Indian investors in the last 5 years?
Immunic Inc stock has given -94.97% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?